These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 25642946

  • 1. Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.
    Pereira L, Abbehusen M, Teixeira C, Cunha J, Nascimento IP, Fukutani K, dos-Santos W, Barral A, de Oliveira CI, Barral-Netto M, Soto M, Brodskyn CI.
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003490. PubMed ID: 25642946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum.
    Martínez-Flórez A, Martori C, Monteagudo PL, Rodriguez F, Alberola J, Rodríguez-Cortés A.
    Parasit Vectors; 2020 Jun 09; 13(1):294. PubMed ID: 32517744
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
    Martins VT, Duarte MC, Chávez-Fumagalli MA, Menezes-Souza D, Coelho CS, de Magalhães-Soares DF, Fernandes AP, Soto M, Tavares CA, Coelho EA.
    Parasit Vectors; 2015 Jul 11; 8():363. PubMed ID: 26160291
    [Abstract] [Full Text] [Related]

  • 10. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G.
    Vaccine; 2005 Apr 22; 23(22):2825-40. PubMed ID: 15780731
    [Abstract] [Full Text] [Related]

  • 11. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA, Gannavaram S, Santiago Hda C, Selvapandiyan A, Souza DM, Passos LS, de Mendonça LZ, Lemos-Giunchetti Dda S, Ricci ND, Bartholomeu DC, Giunchetti RC, Bueno LL, Correa-Oliveira R, Nakhasi HL, Fujiwara RT.
    Vaccine; 2015 Jan 03; 33(2):280-8. PubMed ID: 25475955
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
    Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, Mendonça DVC, Ludolf F, Gomes DA, Rodrigues MA, Chávez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF.
    Mol Immunol; 2019 Feb 03; 106():108-118. PubMed ID: 30594673
    [Abstract] [Full Text] [Related]

  • 13. The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes.
    Soto M, Alonso C, Requena JM.
    Clin Exp Immunol; 2000 Nov 03; 122(2):212-8. PubMed ID: 11091277
    [Abstract] [Full Text] [Related]

  • 14. Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species.
    Lage DP, Martins VT, Duarte MC, Costa LE, Tavares GSV, Ramos FF, Chávez-Fumagalli MA, Menezes-Souza D, Roatt BM, Tavares CAP, Coelho EAF.
    Acta Trop; 2016 Jun 03; 158():220-230. PubMed ID: 26976272
    [Abstract] [Full Text] [Related]

  • 15. Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
    Fiuza JA, Dey R, Davenport D, Abdeladhim M, Meneses C, Oliveira F, Kamhawi S, Valenzuela JG, Gannavaram S, Nakhasi HL.
    PLoS Negl Trop Dis; 2016 Jan 03; 10(1):e0004322. PubMed ID: 26752686
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant.
    Bayih AG, Daifalla NS, Gedamu L.
    PLoS Negl Trop Dis; 2014 Dec 03; 8(12):e3391. PubMed ID: 25500571
    [Abstract] [Full Text] [Related]

  • 18. Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice.
    Saljoughian N, Zahedifard F, Doroud D, Doustdari F, Vasei M, Papadopoulou B, Rafati S.
    Parasite Immunol; 2013 Dec 03; 35(12):397-408. PubMed ID: 23710803
    [Abstract] [Full Text] [Related]

  • 19. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells.
    Carrión J, Folgueira C, Alonso C.
    Vaccine; 2008 May 12; 26(20):2537-44. PubMed ID: 18400342
    [Abstract] [Full Text] [Related]

  • 20. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
    Pirdel L, Farajnia S.
    Scand J Immunol; 2017 Jul 12; 86(1):15-22. PubMed ID: 28426153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.